Wisconsin Pharmacal Company drug recall: MG217 Multi-Symptom Treatment Cream & Skin Protectant
Key facts
- Agency
- U.S. Food and Drug Administration (FDA)
- Program
- Drugs
- Classification
- Class I
- Status
- Ongoing
- Event ID
- 98788
- Recall initiated
- Apr 24, 2026
- Classified by FDA
- May 29, 2026
- Posted in Enforcement Report
- May 27, 2026
- Recalling firm
- Wisconsin Pharmacal Company
- Firm location
- Jackson, WI, United States
- Initiated by
- Voluntary: Firm initiated
- Firm notified customers by
- Letter
- Products in this event
- 1
What to do
Compare the product, lot or serial numbers below with what you have. If you use a prescription drug or medical device in this recall, talk to your pharmacist or health care provider before you stop using it, and follow the firm's instructions.
Reason for recall
Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.
What the classification means
- Class I: FDA's most serious category: there is a reasonable probability that using or being exposed to the product will cause serious health problems or death.
About this recall
The firm started this recall on Apr 24, 2026. FDA classified it 35 days later, on May 29, 2026. Distribution reported by FDA: USA Nationwide and Bahamas Wisconsin Pharmacal Company has 4 recalls in our records.
Recalled products (1)
D-0553-2026 Class I Ongoing
MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.
Codes / lots: Lot #: 1024088, Exp 11/30/2026
Quantity: 690 tubes
Source and freshness
- Source
- U.S. Food and Drug Administration (FDA) Enforcement Report, via the openFDA drug enforcement dataset
- Official notice
- FDA Enforcement Report, event 98788
- Raw record
- openFDA API (JSON)
- Dataset last updated by FDA
- Nov 3, 2026
- Imported by RecallRadar
- Nov 4, 2026
Enforcement Report entries describe recalls FDA has classified. They are not always the same as a company press release. If something here differs from FDA's record, FDA's record is correct — please tell us.